Clinical Decision Support Systems/CDSS Market by Component (Services, Software), Delivery Mode, Product, Application, Model (Knowledge-based), Type (Therapeutic, Diagnostic), Interactivity (Active, Passive), Patient Care Setting - Global Forecast to 2025
[195 Pages Report] The global clinical decision support system market is expected to reach USD 1.8 billion by 2025 from an estimated USD 1.2 billion in 2020 at a CAGR of 9.1% during the forecast period. The key factors propelling the growth of this market are the implementation of government regulations and initiatives to promote the adoption of HIT solutions, increasing adoption of CDSS-enabled EHRs, increasing number of collaborations and partnerships between stakeholders, growing incidence of medication errors, and the rising prominence of mHealth and big data tools. However, the high investment requirements for the implementation of CDSS and the lack of interoperability and data security concerns are expected to restrain the growth of this market during the forecast period.
To know about the assumptions considered for the study, Request for Free Sample Report
COVID-19 Impact on the Clinical decision support system Market
Due to the COVID-19 outbreak, medical practices of all sizes are under immense pressure, and healthcare facilities across the globe have been overwhelmed by the large number of patients visiting them on a daily basis. The emergence of this pandemic has driven the demand for accurate diagnosis and treatment devices in several countries across the globe. In this regard, clinical decision support systems have proven to be very helpful, as they allow healthcare providers to monitor patients using digitally connected non-invasive devices, such as home blood pressure monitors and pulse oximeters. Moreover, the rapid spread of this disease across the globe has resulted in a shortage of hospital beds and healthcare workers. This has driven the demand for connected medical devices for vital signs monitoring.
The COVID-19 pandemic has also increased the need for social distancing among physicians and patients, which has driven the demand for remote patient monitoring and telehealth solutions and the need for the accurate and timely exchange of patient health records. Various players in this market have introduced COVID-19-associated features into their existing EHRs, which are being made available to users free of cost.
Due to the growing patient volumes, the demand for EMR and EHR platforms to manage complex patient data has increased. As a result, hospitals are increasingly focusing on building their capabilities by integrating various hospital systems with EHRs.
Clinical decision support system Market Dynamics
Drivers: Growing incidence of medication error
A medication error is an unintended failure in the drug treatment process that has the potential to adversely affect the health of patients. Mistakes in the prescribing, dispensing, storing, preparation, and administration of medicine are the most common preventable causes of undesired adverse events and present a major public health burden. Proper care is assured when patients and healthcare providers are given access to complete and accurate EHRs that provide a comprehensive patient illness history. Such records can improve diagnoses, prevent errors, save time, and even decrease waiting periods for patients. To achieve quality care, the implementation and successful utilization of CDSS and its complementary systems are mandatory for hospitals and physicians, which is accelerating their adoption across the globe.
Restrains: Data security concerns related to cloud based CDSS
A major concern with cloud based CDSS is that data hosted by the vendor is not as secure as its on-premise counterpart. Patient information is considered sensitive, and a high degree of privacy needs to be maintained so that this information is accessible to authorized users only. Patient information across countries has been under the scanner of legal frameworks, such as the data privacy requirements legislated through HIPAA (Health Insurance Portability and Accountability Act). Similarly, the European Union has the EU Data Protection Regulation in place with implications for the protection of sensitive health data. In many countries, a patient's protected health information (PHI) cannot be moved out of the country of origin. Public cloud faces the same security issues as traditional IT systems and is therefore not preferred. Although private clouds offer more access protocols and systems, the healthcare industry is not assured of its effectiveness.
According to a study conducted by Ermetic, a cybersecurity investigation company, nearly 81% of healthcare organizations have experienced cloud data security breaches in the last 18 months, as of June 2020. Around 31.25% of healthcare organizations experienced breaches where user access was denied. Major concerns related to data security also arise owing to the need for access to patient data through multiple departments. This, in turn, creates security gaps, which can be exploited by hackers to gain access to sensitive information. Thus, several large hospitals still prefer on-premise solutions over cloud-based solutions.
Opportunities: Emerging Asian countries
A number of factors, such as the implementation of government initiatives supporting the adoption of HCIT solutions, rising government healthcare expenditure, and the presence of skilled IT experts in emerging Asian countries, such as China and India, are expected to support the growth of the CDSS market in Asia. Technological advancements are playing a key role as authorities in China are focusing on reforming the countrys healthcare management sector, which is currently facing challenges such as chaotic patient data, underfunded rural health centres, overburdened city hospitals, and a nationwide shortage of doctors.
The Indian government started the Digital India campaign in July 2015 to ensure that government services are made available to citizens electronically by improving IT infrastructure and improving Internet connectivity in the country. Under the Digital India campaign, the e-health initiative will involve the integration of patient EHRs in a digital locker that can be maintained over a lifetime. In this regard, the government issued EMR/EHR Standards in September 2013, which were further revised in December 2016. Similarly, the CDSS market in Japan is expected to grow significantly owing to the rising geriatric population, growing incidence of lifestyle diseases, and strong government initiatives such as the e-Japan policy, the new IT reform strategy, and i-Japan Strategy 2015.
Knowledge-based CDSS can provide reasoning in the face of uncertainties which is often required of CDSS solutions
On the basis of the system model, the market is segmented into knowledge-based CDSS and non-knowledge-based CDSS. In 2019, the knowledge-based CDSS segment accounted for the largest share of ~59% of the market. This segment is also estimated to register the highest CAGR of 10.2% during the forecast period. The large share and high growth of this segment can be attributed to the several beneficial functionalities of knowledge-based CDSS, such as helping clinicians with knowledge-based reasoning to make clinical decisions in the face of uncertainties. These systems can also be integrated into clinical workflows and are less prone to errors as compared to non-knowledge-based systems.
Rising need to control the cost of healthcare to drive the demand for CDSS in ambulatory care settings
Based on the level of interactivity, the CDSS market can be segmented into active CDSS and passive CDSS. The active CDSS segment accounted for the largest share of 58.9% of the market in 2019 and is also projected to grow at the highest CAGR during the forecast period.
Asia Pacific to witness significant growth from 2020 to 2025
Geographically, the clinical decision support system s market is segmented into North America, Europe, Asia Pacific (APAC), and the Rest of the World. The market in the APAC is expected to grow at the highest CAGR over the next five years. Factors such as the presence of a large geriatric population, improved government legislation, high burden of chronic diseases, and the growing focus of various market players on emerging Asian countries are expected to drive the growth of the CDSS market in Asia.
To know about the assumptions considered for the study, download the pdf brochure
Key Market Players
Some of the major market players in the clinical decision support systems market are Cerner (US), Epic (US), MEDITECH (US), Wolters Kluwer Health (Netherlands), Zynx Health (US), Elsevier B.V. (Netherlands), IBM Watson Health (US), Allscripts Healthcare Solutions (US), NextGen Healthcare (US), and Siemens Healthineers (Germany).
Scope of Market
|
Report Metric |
Details |
|
Base year considered |
2019 |
|
Forecast period |
20202025 |
|
Forecast units |
Value (USD Billion) |
|
Segments covered |
By Product, By Application, By Component, By Delivery Mode, By Type, By Model, By level of interactivity, By Settings & By Region |
|
Geographies covered |
North America, Europe, Asia Pacific, ROW |
|
Companies covered |
The major market players include Cerner (US), Epic (US), MEDITECH (US), Wolters Kluwer Health (Netherlands), Zynx Health (US), Elsevier B.V. (Netherlands), IBM Watson Health (US), Allscripts Healthcare Solutions (US), NextGen Healthcare (US), and Siemens Healthineers (Germany). (Total 20 companies) |
By Product
- Integrated CDSS
- Standalone CDSS
By Delivery Mode
- On Premise
- Cloud based
By Model
- Knowledge based
- Non-Knowledge based
By Type
- Therapeutic
- Diagnostic
By Component
- Services
- Software
- Hardware
By Application
- Advanced CDSS
- Conventional CDSS
By Level of Interactivity
- Active CDSS
- Passive CDSS
By Settings
- In Patient
- Ambulatory care settings
By Region
- North America
- US
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe (RoE)
- Asia Pacific
- Japan
- China
- India
- Rest of APAC (RoAPAC)
- RoW
- Latin America
- Middle East and Africa
Recent Developments
- In 2019, Cerner extended its collaboration with Tenet Healthcare corporation to make effective use of Cerners IT solutions across Tenets hospitals to engage patients and providers.
- In 2020, Epic and OCHIN launched the COVID-19 Preparedness Screening app, which helped improve interoperability, care coordination, and overall clinical readiness in the state of Washington, US.
- In 2017, Mayo Clinic partnered with Epic to allow Mayos clinical decision database to merge with Epics EHR.
- In 2018, Wolter Kluwer launched UpToDate Advanced, a guided clinical decision-making solution with dynamic and interactive algorithms as well as lab monographs designed to reduce unwarranted variations in care.
Frequently Asked Questions (FAQ):
What is the market size of the clinical decision support system Market?
The global clinical decision support system market is expected to reach USD 1.86 billion by 2025 from an estimated USD 1.20 billion in 2020 at a CAGR of 9.1% during the forecast period.
What are some of the major drivers for this market?
The key factors propelling the growth of this market are the implementation of government regulations and initiatives to promote the adoption of HIT solutions, increasing adoption of CDSS-enabled EHRs, increasing number of collaborations and partnerships between stakeholders, growing incidence of medication errors, and the rising prominence of mHealth and big data tools.
Who are the major players in the clinical decision support system market?
Cerner (US), Epic (US), MEDITECH (US), Wolters Kluwer Health (Netherlands), Zynx Health (US), Elsevier B.V. (Netherlands), IBM Watson Health (US), Allscripts Healthcare Solutions (US), NextGen Healthcare (US), and Siemens Healthineers (Germany) are considered to be the leading players in the clinical decision support system market.
What is the impact of COVID-19 on the clinical decision support system market?
Due to the COVID-19 outbreak, medical practices of all sizes are under immense pressure, and healthcare facilities across the globe have been overwhelmed by the large number of patients visiting them on a daily basis. The emergence of this pandemic has driven the demand for accurate diagnosis and treatment devices in several countries across the globe. In this regard, clinical decision support systems have proven to be very helpful, as they allow healthcare providers to monitor patients using digitally connected noninvasive devices, such as home blood pressure monitors and pulse oximeters. Moreover, the rapid spread of this disease across the globe has resulted in a shortage of hospital beds and healthcare workers. This has driven the demand for connected medical devices for vital signs monitoring.
The COVID-19 pandemic has also increased the need for social distancing among physicians and patients, which has driven the demand for remote patient monitoring and telehealth solutions and the need for the accurate and timely exchange of patient health records. Various players in this market have introduced COVID-19-associated features into their existing EHRs, which are being made available to users free of cost.
Due to the growing patient volumes, the demand for EMR and EHR platforms to manage complex patient data has increased. As a result, hospitals are increasingly focusing on building their capabilities by integrating various hospital systems with EHRs.
Which region has the highest growth potential in the clinical decision support system market?
The market in the APAC is expected to grow at the highest CAGR over the next five years. Factors such as the presence of a large geriatric population, improved government legislation, high burden of chronic diseases, and the growing focus of various market players on emerging Asian countries are expected to drive the growth of the CDSS market in Asia. .
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
TABLE OF CONTENTS
1 INTRODUCTION (Page No. - 21)
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 INCLUSIONS AND EXCLUSIONS
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE REPORT
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY (Page No. - 24)
2.1 RESEARCH DATA
2.2 RESEARCH METHODOLOGY STEPS
2.2.1 SECONDARY DATA
2.2.1.1 Key data from secondary sources
2.2.2 PRIMARY DATA
2.2.2.1 Key primary insights
2.3 MARKET SIZE ESTIMATION METHODOLOGY
2.4 MARKET DATA ESTIMATION AND TRIANGULATION
2.5 ASSUMPTIONS FOR THE STUDY
2.6 COVID-19-SPECIFIC ASSUMPTIONS
3 EXECUTIVE SUMMARY (Page No. - 33)
4 PREMIUM INSIGHTS (Page No. - 39)
4.1 CLINICAL DECISION SUPPORT SYSTEMS MARKET OVERVIEW
4.2 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT AND COUNTRY
4.3 CLINICAL DECISION SUPPORT SYSTEMS MARKET SHARE, BY PRODUCT
4.4 CLINICAL DECISION SUPPORT SYSTEMS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
5 MARKET OVERVIEW (Page No. - 42)
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Implementation of government regulations and initiatives to promote the adoption of HIT solutions
5.2.1.2 Increasing adoption of CDSS-enabled EHRs
5.2.1.3 Rising number of collaborations and partnerships between stakeholders
5.2.1.4 Growing incidence of medication errors
5.2.1.5 Rising prominence and usage of big data and mHealth tools
5.2.2 RESTRAINTS
5.2.2.1 Data security concerns related to cloud-based CDSS
5.2.2.2 Lack of interoperability
5.2.3 OPPORTUNITIES
5.2.3.1 Emerging Asian countries
5.2.3.2 Technological advancements and social media integration
5.2.4 CHALLENGES
5.2.4.1 Requirement of high investments in infrastructure for implementing CDSS
5.2.4.2 Dearth of skilled IT professionals in the healthcare industry
5.3 IMPACT OF COVID-19 ON THE CLINICAL DECISION SUPPORT SYSTEMS MARKET
5.4 ECOSYSTEM ANALYSIS
5.5 TECHNOLOGY ANALYSIS
6 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT (Page No. - 51)
6.1 INTRODUCTION
6.2 SERVICES
6.2.1 SERVICES SEGMENT TO DOMINATE THE MARKET DURING THE FORECAST PERIOD
6.3 SOFTWARE
6.3.1 THE USE OF EMR/EHR-INTEGRATED CDSS ENABLES ACCESS TO CENTRALIZED PATIENT DATABASES
6.4 HARDWARE
6.4.1 HARDWARE NEEDS TO BE FREQUENTLY UPGRADED OR REPLACED TO MAKE OPTIMAL USE OF THE LATEST SOFTWARE
7 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT (Page No. - 56)
7.1 INTRODUCTION
7.2 INTEGRATED CDSS
7.2.1 INTEGRATED CDSS IS WIDELY USED BY HEALTHCARE PROVIDERS AS IT IMPROVES THE QUALITY OF CARE
7.3 STANDALONE CDSS
7.3.1 STANDALONE CDSS SEGMENT TO ACCOUNT FOR A LOWER SHARE OF THE MARKET
8 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE (Page No. - 60)
8.1 INTRODUCTION
8.2 THERAPEUTIC CDSS
8.2.1 THERAPEUTIC CDSS SEGMENT TO DOMINATE THE MARKET DURING THE FORECAST PERIOD
8.3 DIAGNOSTIC CLINICAL DECISION SUPPORT SYSTEMS
8.3.1 DIAGNOSTIC CDSS GUIDES PHYSICIANS THROUGH THE SYSTEMATIC DIFFERENTIAL DIAGNOSIS PROCESS
9 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL (Page No. - 63)
9.1 INTRODUCTION
9.2 KNOWLEDGE-BASED CDSS
9.2.1 KNOWLEDGE-BASED CDSS CAN PROVIDE REASONING IN THE FACE OF UNCERTAINTIES WHICH IS OFTEN REQUIRED OF CDSS SOLUTIONS
9.3 NON-KNOWLEDGE-BASED CDSS
9.3.1 NON-KNOWLEDGE-BASED CDSS TO ACCOUNT FOR A LOWER SHARE OF THE MARKET
10 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE (Page No. - 67)
10.1 INTRODUCTION
10.2 ON-PREMISE CDSS
10.2.1 ON-PREMISE CDSS SEGMENT TO ACCOUNT FOR THE LARGEST SHARE OF THE MARKET
10.3 CLOUD-BASED CDSS
10.3.1 CLOUD-BASED CDSS SEGMENT TO WITNESS HIGH GROWTH IN THE COMING YEARS
11 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION (Page No. - 71)
11.1 INTRODUCTION
11.2 CONVENTIONAL CDSS
11.2.1 CONVENTIONAL CDSS SEGMENT TO ACCOUNT FOR THE LARGEST SHARE OF THE MARKET
11.3 ADVANCED CLINICAL DECISION SUPPORT SYSTEMS
11.3.1 ADVANCED CDSS SEGMENT TO WITNESS HIGH GROWTH IN THE COMING YEARS
12 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY LEVEL OF INTERACTIVITY (Page No. - 75)
12.1 INTRODUCTION
12.2 ACTIVE CDSS
12.2.1 ACTIVE CDSS IS THE LARGEST AND THE FASTEST-GROWING SEGMENT IN THE CDSS MARKET
12.3 PASSIVE CDSS
12.3.1 PASSIVE CDSS CAUSES MINIMAL DISRUPTION TO WORKFLOWS
13 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING (Page No. - 78)
13.1 INTRODUCTION
13.2 INPATIENT SETTINGS
13.2.1 INPATIENT SETTINGS SEGMENT TO ACCOUNT FOR THE LARGEST SHARE OF THE MARKET
13.3 AMBULATORY CARE SETTINGS
13.3.1 RISING NEED TO CONTROL THE COST OF HEALTHCARE TO DRIVE THE DEMAND FOR CDSS IN AMBULATORY CARE SETTINGS
14 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION (Page No. - 82)
14.1 INTRODUCTION
14.2 NORTH AMERICA
14.2.1 US
14.2.1.1 US is the largest market for CDSS solutions
14.2.2 CANADA
14.2.2.1 Growing need for cost containment to propel market growth
14.3 EUROPE
14.3.1 GERMANY
14.3.1.1 Government initiatives to boost the adoption of EMRs will drive market growth
14.3.2 UK
14.3.2.1 Favorable government initiatives to drive market growth
14.3.3 FRANCE
14.3.3.1 Rising focus on improving the healthcare system in the country to drive market growth
14.3.4 ITALY
14.3.4.1 Growing burden of chronic diseases is driving the demand for CDSS in the country
14.3.5 SPAIN
14.3.5.1 Growing cases of COVID-19 to support the adoption of CDSS
14.3.6 REST OF EUROPE
14.4 ASIA PACIFIC
14.4.1 JAPAN
14.4.1.1 Rising geriatric population in Japan to support market growth
14.4.2 CHINA
14.4.2.1 China is a lucrative market for HCIT solutions due to strong government support for healthcare reforms
14.4.3 INDIA
14.4.3.1 High burden of chronic diseases to support market growth
14.4.4 REST OF ASIA PACIFIC
14.5 REST OF THE WORLD
14.5.1 LATIN AMERICA
14.5.1.1 Developments in healthcare infrastructure to support market growth
14.5.2 MIDDLE EAST AND AFRICA
14.5.2.1 Growing medical tourism to support market growth in the Middle East & Africa
15 COMPETITIVE LANDSCAPE (Page No. - 141)
15.1 OVERVIEW
15.2 MARKET RANKING OF PLAYERS, 2019
15.3 COMPANY EVALUATON MATRIX
15.3.1 INTRODUCTION
15.3.2 COMPANY EVALUATION MATRIX DEFINITIONS AND METHODOLOGY
15.3.3 STARS
15.3.4 EMERGING LEADERS
15.3.5 PARTICIPANTS
15.3.6 PERVASIVE
15.4 COMPETITIVE SCENARIO
15.4.1 PRODUCT LAUNCHES
15.4.2 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS
15.4.3 ACQUISITIONS
15.4.4 EXPANSIONS
16 COMPANY PROFILES (Page No. - 147)
16.1 CERNER
16.1.1 BUSINESS OVERVIEW
16.1.2 PRODUCTS OFFERED
16.1.3 RECENT DEVELOPMENTS
16.1.4 MNM VIEW
16.2 CHANGE HEALTHCARE
16.2.1 BUSINESS OVERVIEW
16.2.2 PRODUCTS OFFERED
16.2.3 RECENT DEVELOPMENTS
16.2.4 MNM VIEW
16.3 EPIC SYSTEMS
16.3.1 BUSINESS OVERVIEW
16.3.2 PRODUCTS OFFERED
16.3.3 RECENT DEVELOPMENTS
16.3.4 MNM VIEW
16.4 MEDITECH
16.4.1 BUSINESS OVERVIEW
16.4.2 PRODUCTS OFFERED
16.4.3 RECENT DEVELOPMENTS
16.4.4 MNM VIEW
16.5 PHILIPS HEALTHCARE (A SUBSIDIARY OF ROYAL PHILIPS ELECTRONICS)
16.5.1 BUSINESS OVERVIEW
16.5.2 PRODUCTS OFFERED
16.5.3 RECENT DEVELOPMENTS
16.5.4 MNM VIEW
16.6 WOLTERS KLUWER HEALTH
16.6.1 BUSINESS OVERVIEW
16.6.2 PRODUCTS OFFERED
16.6.3 RECENT DEVELOPMENTS
16.7 ZYNX HEALTH
16.7.1 BUSINESS OVERVIEW
16.7.2 PRODUCTS OFFERED
16.7.3 RECENT DEVELOPMENTS
16.8 ELSEVIER B.V. (A DIVISION OF RELX GROUP)
16.8.1 BUSINESS OVERVIEW
16.8.2 PRODUCTS OFFERED
16.8.3 RECENT DEVELOPMENTS
16.9 IBM WATSON HEALTH
16.9.1 BUSINESS OVERVIEW
16.9.2 PRODUCTS OFFERED
16.9.3 RECENT DEVELOPMENTS
16.9.4 MNM VIEW
16.10 ALLSCRIPTS HEALTHCARE SOLUTIONS
16.10.1 BUSINESS OVERVIEW
16.10.2 PRODUCTS OFFERED
16.10.3 RECENT DEVELOPMENTS
16.11 ATHENAHEALTH, INC.
16.11.1 BUSINESS OVERVIEW
16.11.2 SERVICES OFFERED
16.11.3 RECENT DEVELOPMENTS
16.12 NEXTGEN HEALTHCARE
16.12.1 BUSINESS OVERVIEW
16.12.2 PRODUCTS & SERVICES OFFERED
16.12.3 RECENT DEVELOPMENTS
16.13 SIEMENS HEALTHINEERS
16.13.1 BUSINESS OVERVIEW
16.13.2 PRODUCTS & SERVICES OFFERED
16.13.3 RECENT DEVELOPMENTS
16.14 ESCBO HEALTH (A DIVISION OF ESCBO INDUSTRIES, INC.)
16.14.1 BUSINESS OVERVIEW
16.14.2 PRODUCTS & SERVICES OFFERED
16.14.3 RECENT DEVELOPMENTS
16.15 GE HEALTHCARE
16.15.1 BUSINESS OVERVIEW
16.15.2 PRODUCTS OFFERED
16.16 ECLINICALWORKS
16.16.1 BUSINESS OVERVIEW
16.16.2 PRODUCTS OFFERED
16.16.3 RECENT DEVELOPMENTS
16.17 RAMPMEDICAL
16.17.1 BUSINESS OVERVIEW
16.17.2 PRODUCTS & SERVICES OFFERED
16.17.3 RECENT DEVELOPMENTS
16.18 MEDICAL ALGORITHMS COMPANY
16.18.1 BUSINESS OVERVIEW
16.18.2 PRODUCTS & SERVICES OFFERED
16.19 HERA-MI
16.19.1 BUSINESS OVERVIEW
16.19.2 PRODUCTS & SERVICES OFFERED
16.20 CUREMD
16.20.1 BUSINESS OVERVIEW
16.20.2 PRODUCTS & SERVICES OFFERED
16.21 MTBC
16.21.1 BUSINESS OVERVIEW
16.21.2 PRODUCTS OFFERED
16.21.3 RECENT DEVELOPMENTS
17 APPENDIX (Page No. - 188)
17.1 DISCUSSION GUIDE
17.2 KNOWLEDGE STORE: MARKETSANDMARKETS SUBSCRIPTION PORTAL
17.3 AVAILABLE CUSTOMIZATIONS
17.4 RELATED REPORTS
17.5 AUTHOR DETAILS
LIST OF TABLES (181 TABLES)
TABLE 1 INDICATIVE LIST OF COLLABORATIONS BETWEEN ORGANIZATIONS FROM 20182020
TABLE 2 TECHNOLOGICAL DEVELOPMENTS BY SOME LEADING VENDORS
TABLE 3 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 20182025 (USD MILLION)
TABLE 4 CLINICAL DECISION SUPPORT SERVICES MARKET, BY REGION, 20182025 (USD MILLION)
TABLE 5 CLINICAL DECISION SUPPORT SOFTWARE MARKET, BY REGION, 20182025 (USD MILLION)
TABLE 6 CLINICAL DECISION SUPPORT HARDWARE MARKET, BY REGION, 20182025 (USD MILLION)
TABLE 7 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 20182025 (USD MILLION)
TABLE 8 INTEGRATED CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION, 20182025 (USD MILLION)
TABLE 9 STANDALONE CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION, 20182025 (USD MILLION)
TABLE 10 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 11 THERAPEUTIC CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION, 20182025 (USD MILLION)
TABLE 12 DIAGNOSTIC CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION, 20182025 (USD MILLION)
TABLE 13 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 20182025 (USD MILLION)
TABLE 14 KNOWLEDGE-BASED CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION, 20182025 (USD MILLION)
TABLE 15 NON-KNOWLEDGE-BASED CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION, 20182025 (USD MILLION)
TABLE 16 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 20182025 (USD MILLION)
TABLE 17 ON-PREMISE CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION, 20182025 (USD MILLION)
TABLE 18 CLOUD-BASED CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION, 20182025 (USD MILLION)
TABLE 19 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 20182025 (USD MILLION)
TABLE 20 CONVENTIONAL CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION, 20182025 (USD MILLION)
TABLE 21 ADVANCED CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION, 20182025 (USD MILLION)
TABLE 22 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY LEVEL OF INTERACTIVITY, 20182025 (USD MILLION)
TABLE 23 ACTIVE CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION, 20182025 (USD MILLION)
TABLE 24 PASSIVE CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION, 20182025 (USD MILLION)
TABLE 25 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 20182025 (USD MILLION)
TABLE 26 CLINICAL DECISION SUPPORT SYSTEMS MARKET FOR INPATIENT SETTINGS, BY REGION, 20182025 (USD MILLION)
TABLE 27 CLINICAL DECISION SUPPORT SYSTEMS MARKET FOR AMBULATORY CARE SETTINGS, BY REGION, 20182025 (USD MILLION)
TABLE 28 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION, 20182025 (USD MILLION)
TABLE 29 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY, 20182025 (USD MILLION)
TABLE 30 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 20182025 (USD MILLION)
TABLE 31 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 20182025 (USD MILLION)
TABLE 32 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 20182025 (USD MILLION)
TABLE 33 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 34 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 20182025 (USD MILLION)
TABLE 35 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY LEVEL OF INTERACTIVITY, 20182025 (USD MILLION)
TABLE 36 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 20182025 (USD MILLION)
TABLE 37 NORTH AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 20182025 (USD MILLION)
TABLE 38 US: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 20182025 (USD MILLION)
TABLE 39 US: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 20182025 (USD MILLION)
TABLE 40 US: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 20182025 (USD MILLION)
TABLE 41 US: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 42 US: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 20182025 (USD MILLION)
TABLE 43 US: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY LEVEL OF INTERACTIVITY, 20182025 (USD MILLION)
TABLE 44 US: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 20182025 (USD MILLION)
TABLE 45 US: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 20182025 (USD MILLION)
TABLE 46 CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 20182025 (USD MILLION)
TABLE 47 CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 20182025 (USD MILLION)
TABLE 48 CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 20182025 (USD MILLION)
TABLE 49 CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 50 CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 20182025 (USD MILLION)
TABLE 51 CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY LEVEL OF INTERACTIVITY, 20182025 (USD MILLION)
TABLE 52 CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 20182025 (USD MILLION)
TABLE 53 CANADA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 20182025 (USD MILLION)
TABLE 54 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY, 20182025 (USD MILLION)
TABLE 55 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 20182025 (USD MILLION)
TABLE 56 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 20182025 (USD MILLION)
TABLE 57 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 20182025 (USD MILLION)
TABLE 58 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 59 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 20182025 (USD MILLION)
TABLE 60 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY LEVEL OF INTERACTIVITY, 20182025 (USD MILLION)
TABLE 61 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 20182025 (USD MILLION)
TABLE 62 EUROPE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 20182025 (USD MILLION)
TABLE 63 GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 20182025 (USD MILLION)
TABLE 64 GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 20182025 (USD MILLION)
TABLE 65 GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 20182025 (USD MILLION)
TABLE 66 GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 67 GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 20182025 (USD MILLION)
TABLE 68 GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY LEVEL OF INTERACTIVITY, 20182025 (USD MILLION)
TABLE 69 GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 20182025 (USD MILLION)
TABLE 70 GERMANY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 20182025 (USD MILLION)
TABLE 71 UK: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 20182025 (USD MILLION)
TABLE 72 UK: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 20182025 (USD MILLION)
TABLE 73 UK: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 20182025 (USD MILLION)
TABLE 74 UK: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 75 UK: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 20182025 (USD MILLION)
TABLE 76 UK: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY LEVEL OF INTERACTIVITY, 20182025 (USD MILLION)
TABLE 77 UK: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 20182025 (USD MILLION)
TABLE 78 UK: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 20182025 (USD MILLION)
TABLE 79 FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 20182025 (USD MILLION)
TABLE 80 FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 20182025 (USD MILLION)
TABLE 81 FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 20182025 (USD MILLION)
TABLE 82 FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 83 FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 20182025 (USD MILLION)
TABLE 84 FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY LEVEL OF INTERACTIVITY, 20182025 (USD MILLION)
TABLE 85 FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 20182025 (USD MILLION)
TABLE 86 FRANCE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 20182025 (USD MILLION)
TABLE 87 ITALY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 20182025 (USD MILLION)
TABLE 88 ITALY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 20182025 (USD MILLION)
TABLE 89 ITALY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 20182025 (USD MILLION)
TABLE 90 ITALY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 91 ITALY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 20182025 (USD MILLION)
TABLE 92 ITALY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY LEVEL OF INTERACTIVITY, 20182025 (USD MILLION)
TABLE 93 ITALY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 20182025 (USD MILLION)
TABLE 94 ITALY: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 20182025 (USD MILLION)
TABLE 95 SPAIN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 20182025 (USD MILLION)
TABLE 96 SPAIN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 20182025 (USD MILLION)
TABLE 97 SPAIN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 20182025 (USD MILLION)
TABLE 98 SPAIN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 99 SPAIN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 20182025 (USD MILLION)
TABLE 100 SPAIN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY LEVEL OF INTERACTIVITY, 20182025 (USD MILLION)
TABLE 101 SPAIN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 20182025 (USD MILLION)
TABLE 102 SPAIN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 20182025 (USD MILLION)
TABLE 103 ROE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 20182025 (USD MILLION)
TABLE 104 ROE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 20182025 (USD MILLION)
TABLE 105 ROE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 20182025 (USD MILLION)
TABLE 106 ROE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 107 ROE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 20182025 (USD MILLION)
TABLE 108 ROE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY LEVEL OF INTERACTIVITY, 20182025 (USD MILLION)
TABLE 109 ROE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 20182025 (USD MILLION)
TABLE 110 ROE: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 20182025 (USD MILLION)
TABLE 111 APAC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COUNTRY, 20182025 (USD MILLION)
TABLE 112 APAC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 20182025 (USD MILLION)
TABLE 113 APAC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 20182025 (USD MILLION)
TABLE 114 APAC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 20182025 (USD MILLION)
TABLE 115 APAC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 116 APAC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 20182025 (USD MILLION)
TABLE 117 APAC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY LEVEL OF INTERACTIVITY, 20182025 (USD MILLION)
TABLE 118 APAC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 20182025 (USD MILLION)
TABLE 119 APAC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 20182025 (USD MILLION)
TABLE 120 JAPAN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 20182025 (USD MILLION)
TABLE 121 JAPAN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 20182025 (USD MILLION)
TABLE 122 JAPAN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 20182025 (USD MILLION)
TABLE 123 JAPAN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 124 JAPAN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 20182025 (USD MILLION)
TABLE 125 JAPAN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY LEVEL OF INTERACTIVITY, 20182025 (USD MILLION)
TABLE 126 JAPAN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 20182025 (USD MILLION)
TABLE 127 JAPAN: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 20182025 (USD MILLION)
TABLE 128 CHINA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 20182025 (USD MILLION)
TABLE 129 CHINA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 20182025 (USD MILLION)
TABLE 130 CHINA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 20182025 (USD MILLION)
TABLE 131 CHINA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 132 CHINA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 20182025 (USD MILLION)
TABLE 133 CHINA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY LEVEL OF INTERACTIVITY, 20182025 (USD MILLION)
TABLE 134 CHINA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 20182025 (USD MILLION)
TABLE 135 CHINA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 20182025 (USD MILLION)
TABLE 136 INDIA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 20182025 (USD MILLION)
TABLE 137 INDIA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 20182025 (USD MILLION)
TABLE 138 INDIA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 20182025 (USD MILLION)
TABLE 139 INDIA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 140 INDIA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 20182025 (USD MILLION)
TABLE 141 INDIA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY LEVEL OF INTERACTIVITY, 20182025 (USD MILLION)
TABLE 142 INDIA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 20182025 (USD MILLION)
TABLE 143 INDIA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 20182025 (USD MILLION)
TABLE 144 ROAPAC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 20182025 (USD MILLION)
TABLE 145 ROAPAC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 20182025 (USD MILLION)
TABLE 146 ROAPAC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 20182025 (USD MILLION)
TABLE 147 ROAPAC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 148 ROAPAC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 20182025 (USD MILLION)
TABLE 149 ROAPAC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY LEVEL OF INTERACTIVITY, 20182025 (USD MILLION)
TABLE 150 ROAPAC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 20182025 (USD MILLION)
TABLE 151 ROAPAC: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 20182025 (USD MILLION)
TABLE 152 ROW: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY REGION, 20182025 (USD MILLION)
TABLE 153 ROW: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 20182025 (USD MILLION)
TABLE 154 ROW: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 20182025 (USD MILLION)
TABLE 155 ROW: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 20182025 (USD MILLION)
TABLE 156 ROW: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 157 ROW: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 20182025 (USD MILLION)
TABLE 158 ROW: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY LEVEL OF INTERACTIVITY, 20182025 (USD MILLION)
TABLE 159 ROW: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 20182025 (USD MILLION)
TABLE 160 ROW: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 20182025 (USD MILLION)
TABLE 161 LATIN AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 20182025 (USD MILLION)
TABLE 162 LATIN AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 20182025 (USD MILLION)
TABLE 163 LATIN AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 20182025 (USD MILLION)
TABLE 164 LATIN AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 165 LATIN AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 20182025 (USD MILLION)
TABLE 166 LATIN AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY LEVEL OF INTERACTIVITY, 20182025 (USD MILLION)
TABLE 167 LATIN AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 20182025 (USD MILLION)
TABLE 168 LATIN AMERICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 20182025 (USD MILLION)
TABLE 169 MIDDLE EAST AND AFRICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 20182025 (USD MILLION)
TABLE 170 MIDDLE EAST AND AFRICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 20182025 (USD MILLION)
TABLE 171 MIDDLE EAST AND AFRICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 20182025 (USD MILLION)
TABLE 172 MIDDLE EAST AND AFRICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 20182025 (USD MILLION)
TABLE 173 MIDDLE EAST AND AFRICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 20182025 (USD MILLION)
TABLE 174 MIDDLE EAST AND AFRICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY LEVEL OF INTERACTIVITY, 20182025 (USD MILLION)
TABLE 175 MIDDLE EAST AND AFRICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 20182025 (USD MILLION)
TABLE 176 MIDDLE EAST AND AFRICA: CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 20182025 (USD MILLION)
TABLE 177 COMPANY EVALUATION MATRIX: EVALUATION CRITERIA
TABLE 178 KEY PRODUCT LAUNCHES
TABLE 179 KEY AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS
TABLE 180 KEY ACQUISITIONS
TABLE 181 KEY EXPANSIONS
LIST OF FIGURES (40 FIGURE)
FIGURE 1 CDSS MARKET SEGMENTATION
FIGURE 2 RESEARCH METHODOLOGY: CDSS MARKET
FIGURE 3 RESEARCH DESIGN
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 5 PRIMARY SOURCES
FIGURE 6 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
FIGURE 7 MARKET SIZE ESTIMATION
FIGURE 8 DATA TRIANGULATION METHODOLOGY
FIGURE 9 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY COMPONENT, 2020 VS. 2025 (USD MILLION)
FIGURE 10 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY PRODUCT, 2020 VS. 2025 (USD MILLION)
FIGURE 11 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY TYPE, 2020 VS. 2025 (USD MILLION)
FIGURE 12 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY MODEL, 2020 VS. 2025 (USD MILLION)
FIGURE 13 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY APPLICATION, 2020 VS. 2025 (USD MILLION)
FIGURE 14 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY DELIVERY MODE, 2020 VS. 2025 (USD MILLION)
FIGURE 15 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY LEVEL OF INTERACTIVITY, 2020 VS. 2025 (USD MILLION)
FIGURE 16 CLINICAL DECISION SUPPORT SYSTEMS MARKET, BY SETTING, 2020 VS. 2025 (USD MILLION)
FIGURE 17 GEOGRAPHICAL SNAPSHOT OF THE CLINICAL DECISION SUPPORT SYSTEMS MARKET
FIGURE 18 GOVERNMENT INITIATIVES FOR THE ADOPTION OF HCIT SOLUTIONS TO DRIVE MARKET GROWTH
FIGURE 19 US DOMINATED THE NORTH AMERICAN MARKET IN 2019
FIGURE 20 INTEGRATED CDSS SEGMENT TO DOMINATE THE MARKET DURING THE FORECAST PERIOD
FIGURE 21 ASIA PACIFIC MARKET TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD
FIGURE 22 CLINICAL DECISION SUPPORT SYSTEMS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 23 PRE- COVID- 19 AND POST- COVID- 19 SCENARIO ON CDSS MARKET
FIGURE 24 NORTH AMERICA TO DOMINATE THE CDSS MARKET DURING THE FORECAST PERIOD
FIGURE 25 NORTH AMERICA: CDSS MARKET SNAPSHOT
FIGURE 26 ASIA PACIFIC: CDSS MARKET SNAPSHOT
FIGURE 27 MARKET EVALUATION FRAMEWORK, 20172020
FIGURE 28 KEY DEVELOPMENTS IN THE CLINICAL DECISION SUPPORT SYSTEMS MARKET
FIGURE 29 GLOBAL CLINICAL DECISION SUPPORT SYSTEMS MARKET: COMPANY EVALUATON MATRIX, 2019
FIGURE 30 CERNER: COMPANY SNAPSHOT (2019)
FIGURE 31 CHANGE HEALTHCARE: COMPANY SNAPSHOT (2019)
FIGURE 32 MEDITECH: COMPANY SNAPSHOT (2019)
FIGURE 33 PHILIPS: COMPANY SNAPSHOT (2019)
FIGURE 34 WOLTERS KLUWER: COMPANY SNAPSHOT (2019)
FIGURE 35 IBM: COMPANY SNAPSHOT (2019)
FIGURE 36 ALLSCRIPTS HEALTHCARE SOLUTIONS: COMPANY SNAPSHOT (2019)
FIGURE 37 NEXTGEN HEALTHCARE: COMPANY SNAPSHOT (2019)
FIGURE 38 SIEMENS HEALTHINEERS: COMPANY SNAPSHOT (2020)
FIGURE 39 GE HEALTHCARE: COMPANY SNAPSHOT (2019)
FIGURE 40 MTBC: COMPANY SNAPSHOT (2019)
This study involved four major activities in estimating the size of the clinical decision support systems market. Exhaustive secondary research was done to collect information on the market, peer market, and parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across value chains through primary research. The bottom-up approach was employed to estimate the overall market size. After that, market breakdown and data triangulation were used to estimate the market size of segments and sub-segments.
Secondary Research
The secondary research process involved the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, company house documents, investor presentations, and SEC filings of companies. Some non-exclusive secondary sources include the Healthcare Information and Management Systems Society (HIMSS), American Medical Informatics Association (AMIA), Agency for Healthcare Research and Quality (AHRQ), American Association of Healthcare Administrative Management (AAHAM), Organisation for Economic Co-operation and Development (OECD), World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), Institute for Health Technology Transformation (iHT2), American Medical Group Association (AMGA), International Association of Health Policy (IAHP), Institute of Population and Public Health (IPPH),Expert Interviews, and MarketsandMarkets Analysis.
Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the clinical decision support system market. It was also used to obtain important information about the key players and market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.
Primary Research
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and related key executives from various key companies and organizations operating in the clinical decision support system market. The primary sources from the demand side included industry experts, consultants, healthcare providers, hospital administration, and government bodies. Primary research was conducted to validate the market segmentation, identify key players in the market, and gather insights on key industry trends and key market dynamics.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the clinical decision support systems market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
- The key players in the industry and markets have been identified through extensive secondary research
- The industrys supply chain and market size, in terms of value, have been determined through primary and secondary research processes
- All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources
Data Triangulation
After arriving at the overall market sizeusing the market size estimation processes as explained abovethe market was split into several segments and sub-segments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, the data triangulation, and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides, in the provider, payer, and other industries.
Report Objectives
- To define, describe, and forecast the global CDSS market based on product, component, delivery mode, type, user model, application, level of interactivity, setting, and region
- To provide detailed information regarding the major factors influencing the growth of the market (such as drivers, restraints, opportunities, and challenges)
- To strategically analyse micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall market
- To analyse the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of the market segments with respect to four main regionsNorth America, Europe, the Asia Pacific, and the Rest of the World (RoW)2
- To profile the key players and comprehensively analyse their market shares and core competencies
- To track and analyse competitive developments such as acquisitions, product launches, expansions, agreements & collaborations, and approvals in the global CDSS market
Available Customizations
MarketsandMarkets offers the following customizations for this market report:
- Additional country-level analysis of clinical decision support system s market.
- Profiling of additional market players (up to 3)
Get in-depth analysis of the COVID-19 impact on the Clinical Decision Support Systems/CDSS Market
Benchmarking the rapid strategy shifts of the Top 100 companies in the Clinical Decision Support Systems/CDSS Market
Request For Special Pricing
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Clinical Decision Support Systems/CDSS Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
Growth opportunities and latent adjacency in Clinical Decision Support Systems/CDSS Market